The Bell-Shaped Curve of Cannabis - CBD Infused Product Users

Financialnewsmedia.com News Commentary

PALM BEACH, Florida, Feb. 5, 2019 /PRNewswire/ -- $5.7 BILLION by next year and $22 BILLION by 2022! That is what the market research firm the Brightfield Group projects, in an article published by the BBC. If anyone has ever wondered who, exactly, is actually buying all of these CBD infused products, here's the answer. The numbers say that "based on a survey of 5,000 CBD users that Brightfield conducted this summer, millennials were the first to begin buying CBD products after various states legalized it. There's also a spike in users in their early thirties, but it drops off among people in their early 40s (the Gen X-ers) and then rises again among baby boomers, who are buying tinctures, creams and capsules to use for conditions associated with ageing like arthritis or chronic pain." Bethany Gomez, the Brightfield Group's research director goes on to say that: "There's also a fairly even split between men and women consumers – although Gomez suggests it used to be that more women bought it." Active Companies from around the market with current developments this week include: Marijuana Company of America, Inc. (OTC:MCOA), Cannabis Strategic Ventures (OTC:NUGS), Aphria Inc. (NYSE:APHA) (TSX:APHA), Medical Marijuana, Inc. (OTC:MJNA), Leafbuyer Technologies, Inc. (OTC:LBUY).

Cannabidiol, or CBD as it's better known – a naturally occurring extract of the cannabis sativa plant – is now so ubiquitous in the US, you'd be forgiven for thinking there are few places it's not available and few ailments it cannot treat. Users say they take it for everything from muscle aches and anxiety to arthritis, epilepsy and Post Traumatic Stress Disorder… and let's not forget Fido. There's CBD oil for him too – with added bacon flavor.

Marijuana Company of America, Inc. (OTCQB:MCOA) BREAKING NEWS: Marijuana Company of America, an innovative hemp and cannabis corporation, is pleased to announce that its wholly owned subsidiary hempSMART™, attended special promotional events for its CBD infused product line during Super Bowl LIII this past weekend. The events included Ray Lewis's "Ray of Hope" Foundation's Gold Jacket for a Purpose event, and a special presentation at the Ice Box Club in Atlanta.

A number of professional athletes, NFL coaches, actors, musicians and other persons of interest attended the events, and were given samples of the Company's hempSMART branded products, including hempSMART™ Brain and hempSMART™ Pain Cream.

Some of the notable attendees were Ray Lewis, Deion Sanders, Andre Reed, Marshawn Lynch, Tyreek Hill, Larry Fitzgerald, Terrell Owens, Candance Parker, Jon Stewart, Andre Reed, Quincy Jones, Malcolm Jenkins, Von Miller, Brandon Marshall, Eddie George, Adrian Peterson, Maroon 5, and the Backstreet Boys.

CEO of MCOA, Donald Steinberg, stated, "Attending the Super Bowl LIII events this past weekend provided a great opportunity for well-known professional athletes and celebrities to discover how amazing and beneficial our products can be for them. MCOA anticipates that the Company will receive added exposure and an increase in brand awareness by exposing well known individuals to our products."

MCOA is looking forward to continue to obtain brand exposure through its involvement at a pre-Oscar event later this month, where the Company expects to give out hempSMART samples to several Hollywood stars. Read this and more news for MCOA at: https://www.financialnewsmedia.com/news-mcoa/ 

In the industry developments and happenings in the market this week include:   

Cannabis Strategic Ventures (OTCPK: NUGS) On January 30, 2019 the company announced its plan to break ground on a 6-acre canopy cultivation site in Northern California which will be known as The NUGS Farm. Complimentary to this land acquisition, the Company has obtained from the State of California over 20 licenses for cannabis manufacturing, distribution and cultivation.

"Establishing The NUGS Farm and securing these licenses are significant milestones for Cannabis Strategic Ventures. We are proud of what we have accomplished at this stage of the company," commented Simon Yu, CEO, Cannabis Strategic Ventures. "As the cannabis industry expands, and as we work to make cannabis legal on a federal level, Cannabis Strategic Ventures will be in position to touch on all areas of cannabis production."

Aphria Inc. (NYSE: APHA) (TSX: APHA) recently announced that it had completed its first transfer of plant cuttings from four of the Company's cannabis strains to Denmark-based Schroll Medical ("Schroll"), as part of the Company's previously announced Strategic Partnership (the "Partnership") with Schroll. The shipment was completed under permits issued by the relevant health authorities, including an export permit from Health Canada, an import permit from the Danish Medicines Agency and a phytosanitary certificate from the Canadian Food Inspection Agency.

"We are pleased to introduce the first four Aphria strains to be produced in Europe, through our strategic alliance with Schroll," said Hendrik Knopp, Managing Director of Aphria Germany, who is overseeing the Partnership on behalf of Aphria and Schroll. "This marks another important milestone for Aphria as we extend our leadership position in the European market, and it gives me joy to be able to say today that we literally have a good thing growing in Europe."

Medical Marijuana, Inc. (OTCPK: MJNA) recently announced that it has garnered news coverage in prominent cannabis industry news publication Growers Network. A Jan. 28, 2019, article entitled "Interview with Dr. Stuart Titus, CEO of Medical Marijuana, Inc." features an interview with Medical Marijuana, Inc. CEO Dr. Stuart Titus discussing the company's many recent accomplishments and the future of the cannabis industry in 2019 and beyond.

"It is an honor to be featured as a thought leader in the industry and I'm glad that I had the opportunity to help share my knowledge about cannabidiol (CBD) with a new audience," Titus said. "We hope that more people will begin to understand the many health and wellness benefits of CBD and support our company as we continue to grow and make tremendous progress in making CBD more readily available worldwide."

Leafbuyer Technologies, Inc. (OTCQB: LBUY) recently announced that its quarterly sales rose 68% in the quarter ending December 31, 2018. The increase reflects the revenue booked in the quarter versus the same quarter of the previous year.

"This announcement of record-setting growth follows the Company's major industry moves, including the launch of both the Leafbuyer Wallet and Leafbuyer Loyalty, as well as the acquisition of California-based, order-ahead application Greenlight in the last quarter," said Mark Breen, COO of Leafbuyer. "Our cannabis dispensary and product customers see the exceptional value in the services we offer, and we will continue to diversify our platforms to more thoroughly serve their needs."

DISCLAIMER: FN Media Group LLC (FNM), which owns and operates Financialnewsmedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with any company mentioned herein. FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNM is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNM expects to be compensated twenty six hundred dollars for news coverage of the current press release issued by Marijuana Company of America, Inc. by a non-affiliated third party. FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

Contact Information:
Media Contact
Email: editor@financialnewsmedia.com
+1(561)325-8757

SOURCE FinancialNewsMedia.com